Safety and Efficacy of Oral Febuxostat in Subjects With Gout

Summary

The purpose of this study is to compare febuxostat allopurinol in subjects with gout.

Conditions

• Gout

Interventions

DRUG

Febuxostat

DRUG

Allopurinol

Sponsors & Collaborators

• Qingdao Shengbang Pharmaceutical Co., Ltd.

  collaborator INDUSTRY

• Xijing Hospital

  lead OTHER

Principal Investigators

• Shenren Chen, M.D. · Second Affiliated Hospital of Shantou University Medical College

• Yangang Wang, M.D. · The Affiliated Hospital of Qingdao University

• Xiumei Liu, M.D. · The First Affiliated Hospital of Shanxi Medical University

• Hong Liu, M.D. · First Affiliated Hospital of Guangxi Medical University

• Yongde Peng, M.D. · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

• Jianqin Wang, M.D. · Lanzhou University Second Hospital

• Jinying Lin, M.D. · People's Hospital of Guangxi Zhuang Autonomous Region

• Haiwang Ji, M.D. · Shaanxi Provincial People's Hospital

• Bin Liu, M.D. · The First Hospital of Jilin University

• Ying Lu, M.D. · Zhejiang Provincial Tongde Hospital

• Peng Liu, M.D. · Guangxi Ruikang Hospital

• Yonghong Zhang, M.D. · Luoyang Orthopedic-Traumatological Hospital

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

70 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2011-07-31

Primary Completion

2013-10-31

Completion

2013-10-31